SCM
URGN icon

Stonepine Capital Management’s UroGen Pharma URGN Stock Holding History

Stonepine Capital Management’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-333,400
Closed -$3.69M – 84
2025
Q1 		$3.69M Buy
333,400
+9,076
+3% +$96.8K 3.59% 6
2024
Q4 		$3.45M Buy
324,324
+43,979
+16% +$527K 2.79% 13
2024
Q3 		$3.56M Buy
+280,345
New +$4.16M 2.25% 14
2023
Q3 		– Sell
-448,508
Closed -$4.64M – 26
2023
Q2 		$4.64M Sell
448,508
-253,027
-36% -$2.79M 1.67% 15
2023
Q1 		$6.48M Sell
701,535
-603,412
-46% -$5.55M 2.17% 12
2022
Q4 		$11.6M Buy
1,304,947
+180,727
+16% +$1.71M 4.87% 7
2022
Q3 		$9.35M Buy
1,124,220
+13,170
+1% +$109K 4.21% 7
2022
Q2 		$9.1M Buy
1,111,050
+842,217
+313% +$5.78M 4.23% 9
2022
Q1 		$2.34M Buy
+268,833
New +$2.1M 0.97% 20

Other funds holding URGN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $51.9B AUM 40.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
JFG
Jefferies Financial Group New York $8.2B AUM 40.95% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $90.6B AUM 36.98% 1-Year Est. Return